Tildrakizumab versus placebo or etanercept for chronic plaque psoriasis (reSURFACE 1 and reSURFACE 2): results from two randomised controlled, phase 3 trials.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Diamant Thaçi Kim A. Papp Kristian Reich Alexandra Boer Kimball Andrew Blauvelt |
| Publication date | June 6, 2017 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |